The SARM1 Toll/Interleukin-1 Receptor Domain Possesses Intrinsic NAD+ Cleavage Activity that Promotes Pathological Axonal Degeneration
Washington University in St. Louis · Hope Center for Neurological Disorders
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
631
total citations
- FWCI
- 24.34
- Percentile
- 100%
- References
- 45
Citations per year
Authors
6Topics & keywords
Topics
Keywords
- Pathological
- Degeneration (medical)
- Neuroscience
- Cell biology
- Interleukin-1 receptor
- Chemistry
- Interleukin 1β
- Receptor
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.
Funding
- HHHoward Hughes Medical Institute
- MDMuscular Dystrophy AssociationAwards: MDA349925, MDA344513
- IOInstitute of Clinical and Translational Sciences
- AJAlvin J. Siteman Cancer Center
- NINational Institutes of HealthAwards: RO1NS087632, RO1AG013730, RO1NS065053
- NCNational Cancer InstituteAward: P30 CA091842
- NINational Institute of General Medical SciencesAward: P41 GM103422
- NCNational Center for Advancing Translational SciencesAward: UL1 TR000448